Crowley, TX, United States of America

Raymond E Conrow

This inventor holds 29 USPTO granted patents, primarily in Prostaglandin Synthesis. Top assignees: Alcon Laboratories, Inc., Alcon, Inc., Alcon Universal Ltd.. Active years: 1992-2010.


% Patents Active = 89.7

Average Co-Inventor Count = 2.1

ph-index = 7

Forward Citations = 239(Granted Patents)


Location History:

  • Fort Worth, TX (US) (1992 - 2001)
  • Crowley, TX (US) (1999 - 2010)

Company Filing History:


Years Active: 1992-2010

Loading Chart...
Areas of Expertise:
1-Alkyl-3-Aminoindazoles
Hydroxyeicosatetraenoic Acid
Prostaglandin Synthesis
Angiostatic Steroids
Carbonic Anhydrase Inhibitors
Chiral Spirofluorenehydantoins
Dry Eye Disorders
Ocular Hypertension
Glaucoma Treatment
Heteroatom-Interrupted Analogs
Substituted Hydrindanes
Stannane Synthesis
29 patents (USPTO):Explore Patents

Raymond E Conrow is a prolific inventor and patent holder from Crowley, TX, United States. With a remarkable total of 13 patents to his name, Conrow has made significant contributions to the field of pharmaceuticals and indazoles.

One of his recent patents is titled "1-alkyl-3-aminoindazoles - Methods of making 1-alkylindazoles," which outlines a process for synthesizing 1-alkyl-3-aminoindazoles. This method involves reacting a 2-alkylaminobenzonitrile with a nitrosating agent, followed by reduction-cyclization of the resulting nitrosamine to form a 1-alkyl-3-aminoindazole. The patent further describes the deamination of the 1-alkyl-3-aminoindazole to form a 1-alkylindazole, which can be utilized for the formation of indazoles, particularly those with pharmaceutical applications. Notably, this process enables the creation of enantiomerically enriched or pure indazoles, including aminoalkyl indazoles.

Another patent attributed to Conrow is titled "Methods of making indazoles," elucidating different approaches to producing indazoles. The disclosed methods primarily involve the reaction of an aromatic aldehyde with a nitrogen source to form a nitroso aromatic aldehyde. Subsequently, this intermediate compound is treated with a reducing agent to yield an indazole. Similar to the previous patent, the indazole derived from this process can then be used to synthesize indazoles with desired pharmaceutical activities. Additionally, the patent highlights the ability to form enantiomerically enriched or pure indazoles, such as aminoalkyl indazoles.

Throughout his career, Conrow has worked with respected companies in the industry, including Alcon, Inc. and Alcon Universal Ltd. Alcon, Inc. is widely recognized as a prominent eye care technology company while Alcon Universal Ltd. was likely a subsidiary or associated entity. Collaborating with other accomplished professionals, Conrow has collaborated with colleagues such as Pete Delgado and Peter G. Klimko.

Raymond E Conrow's patents and inventions illustrate his significant contributions to pharmaceuticals and indazoles. His innovative approaches and techniques have not only advanced the field but have also created new possibilities for the development of pharmaceutically active products.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…